Existing user? Login

Consultation: Ustekinumab

The National Institute for Health and Care Excellence has launched a consultation on draft guidance for ustekinumab (Stelara). The draft guidance proposes to not recommend the use of ustekinumab for treating active psoriatic arthritis in adults when the response to previous non-biological disease-modifying antirheumatic drug therapy has been inadequate. The consultation is available on the NICE website until 17 January 2014.

Citation: Electronicjuice DOI: 10.1211/PJ.2014.11132675

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Сиалис 20 мг

surrogacy motherhood

Наш нужный сайт со статьями про фасадный утеплитель.